Sign in →

Test Code MISC1WARDEB27A Ankylosing Spondylitis (HLA-B27) Genotyping

Department

SEND OUTS

Reference Lab Test Number

0050392

Primary Collection Container

Lavender 4 mL (K3EDTA)

Alternate Collection Container

Pink (K3EDTA)

Transport

Whole blood refrigerated

Preferred Transport Temperature

Refrigerated

Processing

Do not freeze. Transport 3 mL whole blood. (Min: 1 mL)

Stability

Ambient: 72 hours

Refrigerated: 1 week

Frozen: Unacceptable

Minimum Testing Volume

1.0 mL

Reference Range

Negative

Methodology

Polymerase Chain Reaction/Fluorescence Monitoring

Performed

Sunday – Saturday

Reported

4-8 days

CPT Codes

-81400

Unacceptable Conditions

Plasma or serum; collection of specimen in sodium heparin tubes.

Additional Information

Testing forwarded to ARUP Laboratory by Warde Medical Laboratory.

ARUP mnemonic is HLAB27 PCR.

May assist in the diagnosis of ankylosing spondylitis. This test is not diagnostic for ankylosing spondylitis and is only suggestive of the condition if there are other clinical signs and symptoms. Test should not be performed for prenatal diagnosis of ankylosing spondylitis since a positive result is not predictive for the disorder.

Background Information for Ankylosing Spondylitis (HLA-B27) Genotyping:

Characteristics: Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily causes pain and inflammation of the joints between the vertebrae of the spine and the sacroiliac joints. Inflammation and pain may occur in other parts of the body as well. HLA-B27 is strongly associated with ankylosing spondylitis (AS) as well as with Reiter syndrome, anterior uveitis, psoriatic arthritis, and inflammatory bowel disease.

Incidence: Greater than 90 percent of patients with AS are HLA-B27 positive compared to 5-10 percent of the general population.

Penetrance: Two to eight percent of individuals with HLA-B27 will develop AS.

Methodology: Polymerase chain reaction (PCR) and fluorescent hybridization probes.

Analytical Sensitivity & Specificity: 99 percent

Limitations: Rare alleles present in less than 1 percent of most populations will not be detected. Diagnostic errors can occur due to rare sequence variations.